Clinical Trials Logo

Developmental Disabilities clinical trials

View clinical trials related to Developmental Disabilities.

Filter by:

NCT ID: NCT04936269 Recruiting - Activity, Motor Clinical Trials

Psychometric Properties of the Turkish Version of Young Children's Participation and Environment Measure

Start date: April 1, 2021
Phase:
Study type: Observational

The Young Children's Participation and Environment Measure (YC-PEM) is a parent/caregiver reported outcome measure that evaluates the participation status and environmental factors of children under five years old. The aim of this study is to translate the Young Children's Participation and Environment Measure (YC-PEM) into the Turkish language and to investigate the psychometric properties of the Turkish version of YC-PEM in children with typical development and neurodevelopmental disabilities under five years old.

NCT ID: NCT04887129 Completed - Covid19 Clinical Trials

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

Start date: May 3, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the school alter chances of infection? Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe. Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who have a high risk of infection from COVID-19. The study lasts for up to 16 months.

NCT ID: NCT04842500 Active, not recruiting - Clinical trials for Behavior and Behavior Mechanisms

Translational Research to Inform Interventions for Challenging Behavior

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

This project is meant to identify relations between the reinforcement histories of 80 adults with intellectual and developmental disabilities (IDD) and the prevalence of extinction bursts. Extinction bursts, or temporary increases in rates and intensities of behavior during extinction, often preclude the inclusion of extinction in intervention packages meant to suppress severe challenging behavior, despite the fact that extinction is often necessary to generate therapeutic outcomes. Study results will provide insight into how researchers can enhance interventions for the severe challenging behavior of individuals with IDD while mitigating the undesirable collateral effects (i.e., extinction bursts) of therapeutic action (i.e., extinction). Expanded access to study results will be made available to those who inquire after all data have been obtained and analyzed.

NCT ID: NCT04796909 Recruiting - Clinical trials for Developmental Disability

Occupational Performance Coaching With Parents of Young Children With Developmental Disability

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Participation in community activities allows children to meet friends, learns new skills, fosters independence, and paves the foundation for lifelong health. High rates of community participation restriction have been reported in children with developmental disabilities who are aged six years or below, a critical developmental period. Occupational Performance Coaching (OPC), grounded in self-determination theory, is aimed to facilitate children's participation in life situations through coaching parents. Studies have shown that OPC is effective to promote children's activity participation. However, there have been limited randomized controlled trials demonstrating the efficacy of OPC, especially with the specific focus on children's community participation. The investigators propose to evaluate the feasibility and acceptability of conducting a pilot randomized controlled trial of OPC for parents of preschool children with developmental disabilities in Hong Kong, and to test its initial efficacy on promoting children's community participation.

NCT ID: NCT04788537 Completed - Clinical trials for Autism Spectrum Disorder

Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders

Start date: February 16, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to test a novel, three-part cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder. The treatment, named TUNE In (Training to Understand and Navigate Emotions and Interactions), includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings. The Investigators will test the efficacy of TUNE In to improve social functioning in adults with autism spectrum disorder (ASD), using a randomized controlled trial using the SRS-2 as the primary outcome measure.

NCT ID: NCT04732052 Recruiting - Aggression Clinical Trials

The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities

tDCS-RIADD
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Aggressive behaviours are highly prevalent among people with developmental disabilities, both in community and inpatient or residential settings, with adverse consequences for the individuals involved and others. Some predictive factors, particularly impulsivity, are dynamic with neurobiological underpinnings, and as such amenable to change or neuromodulation using non-invasive brain stimulation techniques. With this in mind, we designed an experimental protocol to determine the efficacy of transcranial Direct Current Stimulation (tDCS) as a non-invasive brain stimulation technique to reduce impulsivity and aggression associated with developmental disability.

NCT ID: NCT04726371 Recruiting - Covid19 Clinical Trials

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

Start date: January 8, 2021
Phase: N/A
Study type: Interventional

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings is a research study aimed at developing, implementing, and evaluating a package of interventions specifically designed to reduce COVID-19 and other infectious-disease incidence, hospitalizations, and mortality among staff and adults with Serious Mental Illness and Intellectual and Developmental Disabilities in congregate-living settings.

NCT ID: NCT04689282 Completed - Clinical trials for Autism Spectrum Disorder

Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders

Start date: February 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The investigators have designed an innovative proof-of-concept trial designed to provide data as to whether the speech difficulties in children with developmental dysphasia (DD) are improved with intranasal inhalations of bioactive factors (BF), produced by macrophages of M2 phenotype (M2-BFs). The rationale for this approach is the ability of central nervous system (CNS) to repair and the important role of macrophages in the regulation of this process. It was found that type 2 macrophages (M2) have anti-inflammatory and neurorestorative potential, in contrast to pro-inflammatory and neurotoxic effects of М1 cells. The influence of M2 is largely realized through the production of a wide spectrum of bioactive factors (cytokines, chemokines, growth factors, neuropeptides, microvesicles etc) that inhibit inflammation, protect neurons from apoptosis, stimulate neurogenesis, the growth and remyelination of axons, the formation of new synapses and activate angiogenesis. This study uses M2-BFs, as therapeutic tool, and intranasal administration focusing on nose to brain transport, as a mode of delivery. Expected clinical effects in treated children: improvement of speech understanding, word formation, grammatical structure of speech and formation of coherent speech.

NCT ID: NCT04686565 Recruiting - Covid19 Clinical Trials

Covid-19 Pandemic and Cerebral Palsy

Start date: February 15, 2020
Phase:
Study type: Observational

Investigator aimed to analyzed the effect of Covid-19 pandemic on the physical-psychosocial and cognitive state of the children, to benefit form the health, education services and the caregiver's quality of life with telemedicine.

NCT ID: NCT04654260 Recruiting - Clinical trials for Autism Spectrum Disorder

Behavior Therapy for Irritability in Autism

BTIA
Start date: December 10, 2020
Phase: N/A
Study type: Interventional

This is a clinical trial of a novel intervention, Behavioral Therapy for Irritability and Aggression (BTIA), for adolescents on the autism spectrum. The main goals of BTIA are to help adolescents develop emotion regulation skills to handle frustration and to strengthen skills for navigating the challenging and diverse experiences associated with the transition to adulthood. The study will test whether BTIA can be helpful to adolescents on the autism spectrum and to their families.